Observational studyInternational journal of clinical oncology2026
Real-world safety and effectiveness of nivolumab in patients with cancer of unknown primary: results from a nationwide post-marketing surveillance in Japan.
Akira Kawasaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.